Press release content from PR Newswire. The AP news staff was not involved in its creation.
Clover Biopharmaceuticals Announces Publication of Phase 1 Clinical Trial Data for its Adjuvanted COVID-19 Vaccine Candidates in The Lancet
February 1, 2021 GMT
Clover LOGO (PRNewsfoto/三叶草生物制药有限公司)
Adjuvanted S-Trimer COVID-19 vaccine candidates demonstrated favorable safety and tolerability profiles and strong neutralizing immune responses in a phase 1 trial
Clover plans to initiate a global phase 2/3 trial in the first half of 2021 with an interim analysis for vaccine efficacy potentially in the middle of 2021
CHENGDU, China, Feb. 1, 2021 /PRNewswire/ Clover Biopharmaceuticals (Clover), a global clinical-stage biotechnology company committed to developing transformative biologics as vaccines and therapeutics for the world’s most debilitating diseases, today announced that the data from its Phase 1 clinical trial evaluating the safety and immunogenicity of its
Press release content from Business Wire. The AP news staff was not involved in its creation.
Takeda Completes Sale of TachoSil® to Corza Health
February 1, 2021 GMT
OSAKA, Japan (BUSINESS WIRE) Feb 1, 2021
Takeda Pharmaceutical Company Limited ( TSE:4502/NYSE:TAK ) (“Takeda”) today announced that it has completed the previously announced sale of TachoSil ® Fibrin Sealant Patch (“TachoSil ® ”) to Corza Health, Inc. (“Corza”) for €350 million.
ADVERTISEMENT
TachoSil ® is a surgical patch trusted by medical professionals globally to deliver safe, fast and reliable bleeding control. Under the terms of the transaction, Corza has acquired the assets and licenses that support the development and commercialization of TachoSil®, while Takeda maintains ownership of the manufacturing facility in Linz, Austria. Takeda has entered into a long-term manufacturing & supply agreement, under which it will continue to exclusively manufacture TachoSil
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Mexus Continues To Meet Its Production Goals At Santa Elena Mine; Mabel Property Report Being .
Mexus Gold USFebruary 1, 2021 GMT
CABORCA, Mexico, Feb. 01, 2021 (GLOBE NEWSWIRE) Mexus Gold US (OTCQB: MXSG) (“Mexus” or the “Company) announced that it continues to work the Mexus III area at its Santa Elena mine producing a detachment structure mineral with abundant sericite and oxide filled boxwork averaging 1.02 g/t Au. There are areas with higher grade zones where the silica content is noted often with visible gold. Argonauts 2015 limited drilling program intercepted this zone from 32 to 45 meters in depth with an average grade of 1.05 g/t Au. The Vein 2 area has been drilled for blasting and sampled with average values of 2.3 g/t Au. One initial blast of 250 holes drilled to 6 meters is expected to produce approximately 15,000 to 20,000 tons of mineralized material.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
LION Situated to Take Advantage of the EV Boom Creating a 500% Increase in Graphite Demand
Global Li-Ion Graphite CorpFebruary 1, 2021 GMT
VANCOUVER, British Columbia, Feb. 01, 2021 (GLOBE NEWSWIRE) Global Li-Ion Graphite Corp. (“LION” or, the “Company”) (CSE: LION) With China controlling 70% of the worlds Li-Ion Battery graphite and their ongoing decision to cease exports of any Graphite, this leaves a vacuum for LION and producers outside of China to step up and fill the growing shortage of high-grade Graphite. LION’s Ambato-Arana Malagasy Graphite mines supplied high grade graphite to a hand full of European Industrial Companies up until 2012. Madagascar is ideally situated to supply India, China and Europe with high grade graphite for Batteries and industry.